Scalability: Above average

AI digital therapeutics development can be highly scalable for a solo operator due to the nature of digital products that can be replicated and distributed without direct manual labor. With the ability to create software that can reach a wide audience online, the potential for growth is significant. Time constraints are minimal once the product is developed, allowing for scaling without the need for additional team members. Online resources have shown examples of individuals successfully scaling AI digital therapeutics projects independently.